
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Clover Health Investments Corp (CLOV)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/22/2025: CLOV (5-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 116.8% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.84B USD | Price to earnings Ratio - | 1Y Target Price 4.75 |
Price to earnings Ratio - | 1Y Target Price 4.75 | ||
Volume (30-day avg) 5646453 | Beta 2 | 52 Weeks Range 0.63 - 4.87 | Updated Date 04/22/2025 |
52 Weeks Range 0.63 - 4.87 | Updated Date 04/22/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.14% | Operating Margin (TTM) -6.37% |
Management Effectiveness
Return on Assets (TTM) -4.99% | Return on Equity (TTM) -14.75% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1366824269 | Price to Sales(TTM) 1.34 |
Enterprise Value 1366824269 | Price to Sales(TTM) 1.34 | ||
Enterprise Value to Revenue 1 | Enterprise Value to EBITDA -0.65 | Shares Outstanding 418532000 | Shares Floating 401342764 |
Shares Outstanding 418532000 | Shares Floating 401342764 | ||
Percent Insiders 4.99 | Percent Institutions 22.48 |
Analyst Ratings
Rating 4 | Target Price 4.75 | Buy - | Strong Buy 2 |
Buy - | Strong Buy 2 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Clover Health Investments Corp

Company Overview
History and Background
Clover Health Investments Corp. was founded in 2014 with the mission to improve healthcare outcomes, particularly for seniors. It went public via a SPAC merger with Social Capital Hedosophia Holdings Corp. III in January 2021.
Core Business Areas
- Medicare Advantage Plans: Clover Health offers Medicare Advantage (MA) plans to eligible beneficiaries, focusing on technology-driven care management to improve health outcomes.
- Clover Assistant: Clover Assistant is a software platform provided to physicians, leveraging data and machine learning to offer personalized care recommendations and streamline administrative tasks.
Leadership and Structure
Andrew Toy is the Chief Executive Officer. The company has a board of directors overseeing its operations.
Top Products and Market Share
Key Offerings
- Medicare Advantage Plans: Clover Health provides Medicare Advantage plans, primarily targeting underserved communities. Market share information is difficult to precisely determine, but Clover Health operates in specific geographic markets and competes with larger national players. Competitors include UnitedHealth Group, Humana, and CVS Health (Aetna).
- Clover Assistant: Clover Assistant is a technology platform offered to primary care physicians to improve patient care and practice management. No specific market share data is publicly available. Its success is tied to physician adoption. Competitors include other EHR systems and practice management software vendors.
Market Dynamics
Industry Overview
The healthcare industry is experiencing significant growth, driven by an aging population and rising healthcare costs. Technological innovation and value-based care models are increasingly important.
Positioning
Clover Health positions itself as a technology-driven healthcare company focused on improving outcomes for Medicare Advantage members, particularly those in underserved communities. It competes with larger, established players.
Total Addressable Market (TAM)
The Medicare Advantage market is estimated to be hundreds of billions of dollars. Clover Health is focused on capturing a larger share of this market by leveraging its technology platform to improve care quality and efficiency.
Upturn SWOT Analysis
Strengths
- Technology-driven platform (Clover Assistant)
- Focus on underserved communities
- Potential for improved healthcare outcomes through data analysis
- Strong relationships with physicians in some markets
Weaknesses
- Relatively small market share compared to major players
- Dependence on Medicare Advantage regulations
- History of financial losses
- Concentration in specific geographic markets
Opportunities
- Expansion into new geographic markets
- Increased adoption of Clover Assistant by physicians
- Partnerships with healthcare providers and organizations
- Growing Medicare Advantage market
Threats
- Intense competition from larger, well-established healthcare companies
- Changes in Medicare Advantage regulations
- Rising healthcare costs
- Adverse selection in Medicare Advantage plans
Competitors and Market Share
Key Competitors
- UNH
- HUM
- CVS
- CI
- MOH
Competitive Landscape
Clover Health faces significant competition from larger, more established healthcare companies. Its competitive advantage lies in its technology platform and focus on underserved communities, but it needs to scale its operations and achieve profitability to compete effectively.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Clover Health has experienced revenue growth in recent years, but it has also faced significant financial losses.
Future Projections: Analyst estimates for Clover Health's future growth vary, with projections for continued revenue growth but uncertainty regarding profitability.
Recent Initiatives: Recent initiatives include expanding its geographic footprint, enhancing its Clover Assistant platform, and focusing on improving care quality.
Summary
Clover Health is a technology-driven healthcare company focused on the Medicare Advantage market. While it possesses a unique technology platform and targets underserved communities, it faces intense competition and has a history of financial losses. Future success depends on expanding its market share, achieving profitability, and navigating the evolving regulatory landscape. Investor should look out for changing regulations.
Similar Companies

AMZN

Amazon.com Inc



AMZN

Amazon.com Inc

CI

Cigna Corp



CI

Cigna Corp

CVS

CVS Health Corp



CVS

CVS Health Corp

GOOG

Alphabet Inc Class C



GOOG

Alphabet Inc Class C

HUM

Humana Inc



HUM

Humana Inc

MOH

Molina Healthcare Inc



MOH

Molina Healthcare Inc

UNH

UnitedHealth Group Incorporated



UNH

UnitedHealth Group Incorporated
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market share data is based on available estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Clover Health Investments Corp
Exchange NASDAQ | Headquaters Wilmington, DE, United States | ||
IPO Launch date 2001-01-02 | Co-Founder, CEO & Director Mr. Andrew Toy | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 570 | Website https://www.cloverhealth.com |
Full time employees 570 | Website https://www.cloverhealth.com |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.